Skip to main content

Galera Therapeutics, Inc.

GRTXDelisted Sep 6, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001563577

Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Galera Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−7 vs. Q1 2022
Shares held
10.5M
−734.4K (−6.5%) vs. Q1 2022
Total value
$13.7M
−$13.1M (−48.9%) vs. Q1 2022
New holders
2
5 more added
Sold out
9
18 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 39 institutions
Q1 2021: 54 institutionsQ2 2021: 47 institutionsQ3 2021: 40 institutionsQ4 2021: 44 institutionsQ1 2022: 47 institutionsQ2 2022: 39 institutionsQ3 2022: 33 institutionsQ4 2022: 32 institutionsQ1 2023: 40 institutionsQ2 2023: 55 institutionsQ3 2023: 38 institutionsQ4 2023: 37 institutionsQ1 2024: 36 institutionsQ2 2024: 1 institutionQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ2 2022: $13.7M
Q1 2021: $168.5MQ2 2021: $201.5MQ3 2021: $161.8MQ4 2021: $50.6MQ1 2022: $26.9MQ2 2022: $13.7MQ3 2022: $18.1MQ4 2022: $17.9MQ1 2023: $47.8MQ2 2023: $57.8MQ3 2023: $1.53MQ4 2023: $1.88MQ1 2024: $1.37MQ2 2024: $7.13KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $4Q2 2026: $0
Institutions holding GRTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$4
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20241$7.13K
Q1 202436$1.37M
Q4 202337$1.88M
Q3 202338$1.53M
Q2 202355$57.8M
Q1 202340$47.8M
Q4 202232$17.9M
Q3 202233$18.1M
Q2 202239$13.7M
Q1 202247$26.9M
Q4 202144$50.6M
Q3 202140$161.8M
Q2 202147$201.5M
Q1 202154$168.5M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Galera Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding GRTX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Sofinnova Investments, Inc.3,083,712$4.01M0.36%00.0%Unchanged
Novo Holdings A/S2,459,021$3.20M0.16%00.0%Unchanged
Blackstone Group Inc.1,678,984$2.18M0.01%00.0%Unchanged
Tekla Capital Management LLC898,374$1.17M0.05%00.0%Unchanged
Nan Fung Group Holdings Ltd613,223$797.0K0.55%00.0%Unchanged
Vanguard Group Inc435,974$567.0K0.00%−1,409−0.3%Reduced
BlackRock Inc.314,659$410.0K0.00%−6,633−2.1%Reduced
Renaissance Technologies LLC242,352$315.0K0.00%−196,782−44.8%Reduced
Bridgeway Capital Management, LLC187,000$243.0K0.01%+40,000+27.2%Added
Ensign Peak Advisors, Inc151,777$197.0K0.00%+112,002+281.6%Added
Geode Capital Management, LLC79,364$103.0K0.00%00.0%Unchanged
Two Sigma Investments, LP58,325$76.0K0.00%−101,373−63.5%Reduced
Two Sigma Advisers, LP50,900$66.0K0.00%−99,200−66.1%Reduced
Crestline Management, LP34,305$45.0K0.01%−444−1.3%Reduced
Susquehanna International Group, LLP30,278$39.0K0.00%−29,546−49.4%Reduced
BIT Capital GmbH30,000$39.0K0.01%−20,000−40.0%Reduced
State Street Corp28,764$37.0K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.22,311$29.0K0.00%00.0%Unchanged
Millennium Management LLC18,530$24.0K0.00%−38,051−67.3%Reduced
Northern Trust Corp18,175$24.0K0.00%00.0%Unchanged
Citadel Advisors LLC15,930$21.0K0.00%−122,654−88.5%Reduced
Virtu Financial LLC14,491$19.0K0.00%+2,030+16.3%Added
HSBC Holdings PLC12,886$17.0K0.00%−152−1.2%Reduced
Goldman Sachs Group Inc11,637$15.0K0.00%−4,201−26.5%Reduced
Citigroup Inc11,599$15.0K0.00%+11,599New
Taylor Wealth Management Partners10,700$14.0K0.01%−935−8.0%Reduced
Royal Bank of Canada9,210$12.0K0.00%−43−0.5%Reduced
TCI Wealth Advisors, Inc.6,162$8.00K0.00%00.0%Unchanged
Morgan Stanley4,107$6.00K0.00%−1,441−26.0%Reduced
US Bancorp3,383$4.00K0.00%+2,000+144.6%Added
Bank of America Corp2,919$3.00K0.00%−1,907−39.5%Reduced
Wells Fargo & Company2,063$3.00K0.00%+6+0.3%Added
Federation des caisses Desjardins du Quebec2,100$2.73K0.00%00.0%Unchanged
Simplex Trading, LLC1,729$2.00K0.00%−16,834−90.7%Reduced
Cutler Group LP1,600$2.00K0.00%−100−5.9%Reduced
Captrust Financial Advisors1,000$1.00K0.00%00.0%Unchanged
FNY Investment Advisers, LLC1,500$1.00K0.00%+1,500New
JPMorgan Chase & Co24$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.107$00.00%00.0%Unchanged
Belvedere Trading LLC0$00.00%−101,413−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−37,693−100.0%Sold out
Group One Trading, L.P.0$00.00%−34,353−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−30,442−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−26,600−100.0%Sold out
Marshall Wace, LLP0$00.00%−18,004−100.0%Sold out
Bank of Montreal0$00.00%−5,800−100.0%Sold out
UBS Group AG0$00.00%−6,200−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,316−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed